InsidersTradesSigma
Biocon Limited: management transactions · India · SEBI (PIT + SAST)
SEBI:biocon-limitedIN·SEBI (PIT + SAST)Mcap 408.7Bn€
Browse the full insider trade history of Biocon Limited, a publicly traded company based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €408.7bn. The latest transaction was filed on 4 April 2024 — Pledge. Among the most active insiders: MANEESH H GHILDYAL. The full history is accessible without an account.
275
Insider Decl.
0
Thresholds
€28m
136 ops.
Buy Volume
€10m
127 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
426.25 €
Income statement
Revenue150.52 Bn€
Gross profit98.54 Bn€65% margin
Net income10.13 Bn€6.7% margin
Balance sheet & cash
Market cap408.73 Bn€
Total debt183.62 Bn€
Free Cash Flow17.18 Bn€
Last declaration on 4 April 2024
Declarations275 total
Executives●Pledge0SEBI
€175,83061,827 shares@ €2.8439
Equity Shares
SEBI:d33423a0ae50c4940d55377ef2ebf5b3f1994265·
Executives●Pledge0SEBI
€20,8337,328 shares@ €2.8429
Equity Shares
SEBI:c78f095209f404792fd65f44b2c74f009929367e·
Executives●Sale0SEBI
€58,58919,998 shares@ €2.9297
Equity Shares
SEBI:c5839accdeefcf11dbce01d25734d202a6bb77f5·
Executives●Sale0SEBI
€31,76411,000 shares@ €2.8877
Equity Shares
SEBI:ed16c3fd0c3b26e381e0866cdacdf32892ac94ed·
Executives●Purchase0SEBI
€18,9266,792 shares@ €2.7865
Equity Shares
SEBI:8c02a46ef9e9423c1c87d009b7223b85c370dd1c·
Ideal exit: 11 Dec 2024 (T+270)
Executives●Sale0SEBI
€3,0671,000 shares@ €3.0666
Equity Shares
SEBI:c8faefb6f687fedbbd2bd70e9c52d31f245f90fa·
Executives●Sale0SEBI
€6,0252,000 shares@ €3.0127
Equity Shares
SEBI:ed4c1879ec720ca56279261cbcb527ab0623aa97·
Executives●Sale0SEBI
€15,6055,000 shares@ €3.1209
Equity Shares
SEBI:7232bad934bf214da087dd015e0eabf8cfedd242·
Executives●Sale0SEBI
€3,0821,000 shares@ €3.0822
Equity Shares
SEBI:0f67abf84d1abf1a8100e4c3baa4aec831e28dfe·
Executives●Sale0SEBI
€3,0961,000 shares@ €3.0955
Equity Shares
SEBI:8c72120d5d04071253ec5e5e6b5eb2eb855cde30·
Executives●Purchase0SEBI
€62,58120,500 shares@ €3.0527
Equity Shares
SEBI:1dc30af5c2b2bda027dd78ecc0f7201ae33dcf8c·
Ideal exit: 25 Nov 2024 (T+270)
Executives●Sale0SEBI
€6,2052,000 shares@ €3.1027
Equity Shares
SEBI:fa3811b1d532f786d15662e39554072f8dbca8cc·
Executives●Sale0SEBI
€3,0841,000 shares@ €3.0839
Equity Shares
SEBI:6425d6aa8d074f3e64f9598813600bf3d19563b5·
Executives●Sale0SEBI
€14,9745,000 shares@ €2.9948
Equity Shares
SEBI:68ae0f0041478b87778fbe50351ed7a2f775661c·
Executives●Sale0SEBI
€5,9442,000 shares@ €2.9722
Equity Shares
SEBI:19d39aa5e7b35b616b3e7dca35b0178811a620e8·
Executives●Sale0SEBI
€9,0263,000 shares@ €3.0086
Equity Shares
SEBI:408a5483dc17e22ad22a6f5203faa4780d60d492·
Executives●Sale0SEBI
€3,0461,000 shares@ €3.0463
Equity Shares
SEBI:07a977f84876cf829f0ee8fed71af8bcf4a5651c·
Executives●Sale0SEBI
€16,0255,944 shares@ €2.6959
Equity Shares
SEBI:445c651aaa33be3b246ec5f3ae1539cf00efd8d9·
Executives●Purchase0SEBI
€13,3684,980 shares@ €2.6843
Equity Shares
SEBI:50c8c5bdda04c372615367c7790c7336db7f49e2·
Ideal exit: 24 Sept 2024 (T+270)
Executives●Purchase0SEBI
€21,4938,007 shares@ €2.6843
Equity Shares
SEBI:b5b7c42d85acb43edb8dcb2f9bc0cb6a4d5a5eba·
Ideal exit: 24 Sept 2024 (T+270)
Executives●Purchase0SEBI
€96,63536,000 shares@ €2.6843
Equity Shares
SEBI:fb9f062186e70566c08ac2b200d406d5d13f026f·
Ideal exit: 24 Sept 2024 (T+270)
Executives●Sale0SEBI
€5,3842,000 shares@ €2.692
Equity Shares
SEBI:ab85a60903abea137b410ce909048f44ab90ed1c·
Executives●Sale0SEBI
€5,4472,000 shares@ €2.7235
Equity Shares
SEBI:2e5c1d16262dd65df0a62a4a844a818c68cc94c9·
Executives●Sale0SEBI
€8,3363,000 shares@ €2.7788
Equity Shares
SEBI:ce9fce6fdcfa0c1b3007731ef1b22b0a907ba0dd·
Executives●Purchase0SEBI
€13,4705,001 shares@ €2.6934
Equity Shares
SEBI:899d5dbf88c4de7057755889e35164ec96eb7970·
Ideal exit: 17 Sept 2024 (T+270)
25 of 275 declarations